Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for HRMY

Stock NameHarmony Biosciences Holdings
TickerHRMY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4131971040

Show aggregate HRMY holdings

News associated with HRMY

Harmony Biosciences Holdings Breaks Below 200-Day Moving Average - Notable for HRMY
In trading on Tuesday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.34, changing hands as low as $33.45 per share. Harmony Biosciences Holdings Inc shares are currently trading off about 6.4% on the day. The chart - 2025-09-09 12:41:14
Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/5/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.HARMONY BIOSCIENCES HOLDINGS INC (HRMY) is a mid-cap value stock - 2025-09-05 06:14:36
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lowered its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 13.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,165 shares of the company’s stock after selling 1,693 shares during the period. Maryland […] - 2025-08-17 05:17:01
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $51.00 Average Price Target from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned an average recommendation of “Buy” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-08-13 03:14:50
Harmony Biosciences (NASDAQ:HRMY) Rating Lowered to Hold at Wall Street Zen
Wall Street Zen cut shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday morning. Several other research analysts have also issued reports on HRMY. Needham & Company LLC reiterated a “buy” rating and issued a $49.00 price target on […] - 2025-08-12 04:34:55
Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/7/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.GRIFFON CORP (GFF) is a mid-cap value stock in the Appliance &am - 2025-08-07 06:54:43
Arizona State Retirement System Purchases 737 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Arizona State Retirement System grew its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 6.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,261 shares of the company’s stock after buying an additional 737 […] - 2025-07-23 05:44:46
Bank of New York Mellon Corp Has $8.70 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Bank of New York Mellon Corp lowered its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 1.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 262,238 shares of the company’s stock after selling 3,401 shares during the quarter. Bank of New York Mellon Corp’s holdings in Harmony Biosciences were worth […] - 2025-07-22 06:49:00
Truist Financial Begins Coverage on Harmony Biosciences (NASDAQ:HRMY)
Research analysts at Truist Financial initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Get Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $48.00 price target on the stock. Truist Financial’s price target would indicate a potential upside of 36.17% from the company’s current price. […] - 2025-07-22 04:58:48
Louisiana State Employees Retirement System Sells 500 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Louisiana State Employees Retirement System trimmed its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.7% in the first quarter, Holdings Channel reports. The firm owned 18,000 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Harmony Biosciences were worth $597,000 as […] - 2025-07-21 05:16:49
Principal Financial Group Inc. Buys 4,753 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Principal Financial Group Inc. lifted its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 213,416 shares of the company’s stock after purchasing an additional 4,753 shares during the […] - 2025-07-16 04:38:44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.63 Consensus PT from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […] - 2025-06-24 02:36:53
Exchange Traded Concepts LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Exchange Traded Concepts LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 30,256 shares of the company’s stock, valued at approximately $1,004,000. Exchange Traded Concepts LLC owned 0.05% of Harmony […] - 2025-06-20 05:16:57
Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/13/2025
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.CUREVAC BV (CVAC) is a small-cap value stock in the Biotechnolog - 2025-06-13 06:35:45
Harmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMA
In trading on Thursday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.67, changing hands as low as $34.50 per share. Harmony Biosciences Holdings Inc shares are currently trading down about 1.6% on the day. The char - 2025-06-05 12:53:08
Squarepoint Ops LLC Has $582,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Squarepoint Ops LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 125.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 16,901 shares of the company’s stock after purchasing an additional 9,411 shares during the period. Squarepoint Ops LLC’s holdings in Harmony Biosciences […] - 2025-06-04 05:06:50
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 94,011 shares of the company’s stock, valued at approximately $3,235,000. Universal Beteiligungs und Servicegesellschaft mbH owned […] - 2025-06-03 05:10:48
Nuveen Asset Management LLC Has $7.31 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Nuveen Asset Management LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 4.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 212,351 shares of the company’s stock after buying an additional 8,193 shares during the quarter. Nuveen Asset Management LLC’s holdings in Harmony Biosciences were worth […] - 2025-05-30 05:00:50
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LP
Two Sigma Advisers LP grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 21.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,900 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Two […] - 2025-05-27 06:37:02
ProShare Advisors LLC Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
ProShare Advisors LLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 47.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,190 shares of the company’s stock after purchasing an additional 4,534 shares during the period. […] - 2025-05-27 06:00:51
Bank of America Corp DE Lowers Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Bank of America Corp DE lessened its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,508 shares of the company’s stock after selling 113,458 shares during the quarter. Bank […] - 2025-05-27 05:16:49
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts
Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have been given an average rating of “Buy” by the nine brokerages that are currently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average […] - 2025-05-27 02:48:52
Comerica Bank Has $464,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Comerica Bank grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.6% in the fourth quarter, HoldingsChannel reports. The fund owned 13,495 shares of the company’s stock after acquiring an additional 2,919 shares during the period. Comerica Bank’s holdings in Harmony Biosciences were worth $464,000 as of its most […] - 2025-05-16 05:20:57
Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)
Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $49.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 46.44% from the stock’s previous close. […] - 2025-05-08 04:40:44
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Better-Than-Expected Earnings
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.96, but opened at $31.11. Harmony Biosciences shares last traded at $31.61, with a volume of 147,182 shares changing hands. The company reported […] - 2025-05-08 02:25:26
How The Pieces Add Up: IJR Headed For $129
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:51:52
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […] - 2025-05-05 02:49:06
Barclays PLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 31.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,872 shares of the company’s stock after purchasing an additional 24,010 shares during the […] - 2025-04-29 05:22:55
UBS Group Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price
Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price target lowered by UBS Group from $55.00 to $48.00 in a research note released on Monday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock. A number of other equities analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-04-29 04:28:55
Envestnet Asset Management Inc. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Envestnet Asset Management Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 53,826 shares of the company’s stock after buying an additional 1,321 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Harmony Biosciences were worth $1,852,000 at […] - 2025-04-28 04:37:03

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) HRMY holdings

DateNumber of HRMY Shares HeldBase Market Value of HRMY SharesLocal Market Value of HRMY SharesChange in HRMY Shares HeldChange in HRMY Base ValueCurrent Price per HRMY Share HeldPrevious Price per HRMY Share Held
2025-11-12 (Wednesday)37,020USD 1,241,651USD 1,241,651
2025-11-11 (Tuesday)36,925USD 1,217,787HRMY holding increased by 42833USD 1,217,7870USD 42,833 USD 32.98 USD 31.82
2025-11-10 (Monday)36,925HRMY holding increased by 94USD 1,174,954HRMY holding increased by 17356USD 1,174,95494USD 17,356 USD 31.82 USD 31.43
2025-11-07 (Friday)36,831USD 1,157,598HRMY holding increased by 18047USD 1,157,5980USD 18,047 USD 31.43 USD 30.94
2025-11-06 (Thursday)36,831HRMY holding increased by 94USD 1,139,551HRMY holding decreased by -12154USD 1,139,55194USD -12,154 USD 30.94 USD 31.35
2025-11-05 (Wednesday)36,737USD 1,151,705HRMY holding increased by 23144USD 1,151,7050USD 23,144 USD 31.35 USD 30.72
2025-11-04 (Tuesday)36,737HRMY holding increased by 95USD 1,128,561HRMY holding increased by 53851USD 1,128,56195USD 53,851 USD 30.72 USD 29.33
2025-11-03 (Monday)36,642USD 1,074,710HRMY holding increased by 27848USD 1,074,7100USD 27,848 USD 29.33 USD 28.57
2025-10-31 (Friday)36,642USD 1,046,862HRMY holding decreased by -12092USD 1,046,8620USD -12,092 USD 28.57 USD 28.9
2025-10-30 (Thursday)36,642HRMY holding increased by 475USD 1,058,954HRMY holding decreased by -1462USD 1,058,954475USD -1,462 USD 28.9 USD 29.32
2025-10-29 (Wednesday)36,167HRMY holding increased by 190USD 1,060,416HRMY holding decreased by -5942USD 1,060,416190USD -5,942 USD 29.32 USD 29.64
2025-10-28 (Tuesday)35,977USD 1,066,358HRMY holding decreased by -16909USD 1,066,3580USD -16,909 USD 29.64 USD 30.11
2025-10-27 (Monday)35,977USD 1,083,267HRMY holding decreased by -5037USD 1,083,2670USD -5,037 USD 30.11 USD 30.25
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of HRMY by Blackrock for IE00BYXG2H39

Show aggregate share trades of HRMY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY9432.06531.140 31.232USD 2,936 33.38
2025-11-06BUY9431.58030.340 30.464USD 2,864 33.40
2025-11-04BUY9530.89027.660 27.983USD 2,658 33.42
2025-10-30BUY47529.50028.740 28.816USD 13,688 33.50
2025-10-29BUY19029.32029.755 29.711USD 5,645 33.52
2025-10-22SELL-38026.27026.490 26.468USD -10,058 33.63 Profit of 2,723 on sale
2025-10-20BUY19026.02026.180 26.164USD 4,971 33.72
2025-10-17BUY47425.90026.130 26.107USD 12,375 33.76
2025-10-15BUY75226.63026.890 26.864USD 20,202 33.80
2025-10-03BUY66527.28027.430 27.415USD 18,231 33.87
2025-10-02BUY9526.76026.815 26.810USD 2,547 33.91
2025-09-30BUY19027.56028.000 27.956USD 5,312 33.99
2025-09-26BUY19027.51027.570 27.564USD 5,237 34.06
2025-09-25BUY19027.04027.062 27.060USD 5,141 34.10
2025-09-24SELL-1,65726.76030.287 29.934USD -49,601 34.15 Profit of 6,981 on sale
2025-09-18BUY10032.63032.700 32.693USD 3,269 34.16
2025-09-17BUY30032.06032.840 32.762USD 9,829 34.17
2025-08-20SELL-39636.63036.640 36.639USD -14,509 34.13 Loss of -994 on sale
2025-07-30BUY39635.48035.885 35.844USD 14,194 34.06
2025-07-17SELL-19836.43036.710 36.682USD -7,263 33.93 Loss of -545 on sale
2025-07-11SELL-80034.00034.570 34.513USD -27,610 33.91 Loss of -482 on sale
2025-07-07BUY30032.24032.870 32.807USD 9,842 33.92
2025-07-02BUY5,50032.11032.370 32.344USD 177,892 33.95
2025-06-20BUY81631.89032.600 32.529USD 26,544 33.97
2025-06-13BUY81832.97033.260 33.231USD 27,183 34.01
2025-06-11BUY18835.14036.390 36.265USD 6,818 34.01
2025-06-10BUY18835.85036.470 36.408USD 6,845 34.00
2025-06-04SELL-9435.16035.960 35.880USD -3,373 33.96 Loss of -181 on sale
2025-04-23BUY9428.90029.997 29.887USD 2,809 34.27
2025-04-10SELL-75228.99029.330 29.296USD -22,031 34.82 Profit of 4,156 on sale
2025-04-08SELL-9428.13029.762 29.599USD -2,782 34.97 Profit of 504 on sale
2025-04-07SELL-9428.40029.130 29.057USD -2,731 35.04 Profit of 563 on sale
2025-04-04SELL-47029.26030.480 30.358USD -14,268 35.11 Profit of 2,233 on sale
2025-04-01BUY39232.42033.250 33.167USD 13,001 35.17
2025-03-31SELL-28233.19033.420 33.397USD -9,418 35.20 Profit of 508 on sale
2025-03-21BUY1,39235.28035.510 35.487USD 49,398 35.31
2025-03-14SELL-1,44032.72033.050 33.017USD -47,544 35.39 Profit of 3,419 on sale
2025-03-07SELL-18033.67034.630 34.534USD -6,216 35.53 Profit of 179 on sale
2025-03-04SELL-9032.61033.650 33.546USD -3,019 35.63 Profit of 188 on sale
2025-02-25BUY18036.97037.430 37.384USD 6,729 35.78
2025-02-19SELL-8935.32037.055 36.882USD -3,282 35.86 Loss of -91 on sale
2025-02-13BUY26739.07539.900 39.818USD 10,631 35.61
2025-02-12BUY8937.84038.790 38.695USD 3,444 35.56
2025-02-11BUY35637.74038.665 38.573USD 13,732 35.52
2024-12-30SELL-3,10734.06034.520 34.474USD -107,111 34.39 Loss of -266 on sale
2024-11-18SELL-1,47033.07033.310 33.286USD -48,930 34.72 Profit of 2,104 on sale
2024-11-08SELL-9836.08036.080 36.080USD -3,536 34.59 Loss of -146 on sale
2024-10-21SELL-9834.95035.440 35.391USD -3,468 0.00 Loss of -3,468 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of HRMY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19108,4725,348234,71146.2%
2025-09-18111,0258,894325,98434.1%
2025-09-1795,108100187,88350.6%
2025-09-16128,09712,358317,22640.4%
2025-09-15135,2090300,08245.1%
2025-09-12151,9232,495255,31559.5%
2025-09-11161,5659,535281,36157.4%
2025-09-10113,5953,149207,04354.9%
2025-09-09206,18322,917461,81744.6%
2025-09-08186,74962,734443,99742.1%
2025-09-0584,99223,242293,94528.9%
2025-09-04133,57521,855288,00646.4%
2025-09-03241,435124,278394,90361.1%
2025-09-02137,28152,607257,77153.3%
2025-08-2996,24839,096140,24868.6%
2025-08-2897,9100133,98773.1%
2025-08-27104,114500187,48255.5%
2025-08-2657,186093,88160.9%
2025-08-2584,4000146,26357.7%
2025-08-2247,5300213,94922.2%
2025-08-2184,1022,300140,92859.7%
2025-08-2098,6900183,56353.8%
2025-08-1980,0390168,82047.4%
2025-08-1883,964303156,50753.6%
2025-08-1569,4878121,07657.4%
2025-08-1471,337844119,72159.6%
2025-08-1380,92726168,51548.0%
2025-08-1276,33123129,34259.0%
2025-08-1198,526506189,09152.1%
2025-08-0875,5290129,88758.1%
2025-08-0780,0520140,75156.9%
2025-08-0698,3506,300192,17351.2%
2025-08-05267,646547468,85257.1%
2025-08-04151,9880230,05366.1%
2025-08-01111,29534186,98859.5%
2025-07-3175,1870140,32653.6%
2025-07-3092,0850197,55146.6%
2025-07-29103,04338188,11754.8%
2025-07-28122,3000234,86952.1%
2025-07-25111,0750232,33247.8%
2025-07-2476,5830125,41461.1%
2025-07-23107,72219215,18650.1%
2025-07-22258,6511,287348,81674.2%
2025-07-21210,1510270,41377.7%
2025-07-18133,326960251,00353.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.